Frontlight ResearchEarly access
Trial site
Indiana Blood and Marrow Institute
- 3closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Completed3 trials
- Lead sponsor
- Novartis Pharmaceuticals3 trials
Closed trials
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 12 Nov 2026